Table 5.

Percent change in adolescent 8-isoprostane per 1-unit increase in urinary ln-transformed prenatal maternal urinary BPA.

Trimester of exposure	Adolescent 8-isoprostane
	Model 1: Unadjusted				Model 2: A priori covariates
	N	BPA	MDS	BPA *MDS	N	BPA	MDS	BPA *MDS
		% Δ	% Δ	% Δ		% Δ	% Δ	% Δ
Entire Sample
Trimester one	192	0.162	−0.002	−0.024	185	0.079	−0.019	−0.004
Trimester two	186	0.114	0.011	−0.009	185	0.203b	0.009	−0.025
Trimester three	216	0.054	0.010	0.001	209	0.078	−0.001	−0.001
Females
Trimester one	103	−0.040	0.005	0.008	100	−0.089	0.004	0.019
Trimester two	103	0.239b	0.066a	−0.048b	100	0.237b	0.064a	−0.046b
Trimester three	111	0.205	0.034b	−0.034	108	0.186	0.024	−0.027
Males
Trimester one	89	0.544a	−0.011	−0.092a	85	0.381	−0.041	−0.052
Trimester two	89	0.084	−0.027	0.009	85	0.228	−0.056	−0.011
Trimester three	105	−0.089	−0.014	0.038	101	−0.034	−0.033	0.029

ABR: BPA: Bisphenol A; MDS: Mediterranean diet score Model 1: Unadjusted (only adjusted for trimester specific SG urinary BPA); Model 2: Maternal variables (adjusted for trimester specific SG urinary BPA, education level) and adolescent variables (pubertal status, urinary BPA, and Mediterranean diet score adherence);

^ap < 0.05,

^bp < 0.10.